Severity, reduction or cessation in nausea/vomiting 2. Number of episodes of emesis 3. Quality of life outcomes 4. Pregnancy complications 5. Adverse fetal/neonatal outcomes · Pregnant women with hyperemesis gravidarum
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Duration of hospital admission (days) · Pregnant women with hyperemesis gravidarum
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Acceptability: dropouts during intervention period Rate of dropouts and adverse events · Patients with idiopathic Parkinson's disease
1 finding from 1 review
Swallowing function/efficiency Measured using a rating of oropharyngeal swallowing efficiency (OPSE) quantifying the interaction of the speed of bolus movement and safety/efficiency in clearing material from the oropharynx Dysphagia is defined as ... · adults with advanced head and neck cancer
It is very uncertain whether therapeutic swallowing exercises changes swallowing function/efficiency Measured using a rating of… compared with treatment (very low certainty).
1 finding from 1 review
Fetal bradycardia (primary) · patients with breech presentation
Regional analgesia (with tocolysis) showed no clear difference in fetal bradycardia (primary) compared with no intervention of regional analgesia (with or without tocolysis) (low certainty).
1 finding from 1 review
Fetal bradycardia (primary) · patients with breech presentation
It is very uncertain whether beta stimulant changes fetal bradycardia (primary) compared with placebo (very low certainty).
1 finding from 1 review
Preterm prelabour rupture of membranes · pregnant women receiving vitamin E supplementation or control, living in areas where there is either inadequate dietary intake of vitamin…
Any vitamin E supplementation showed no clear difference in prelabour rupture of fetal membranes ‐ preterm compared with placebo, no placebo or other supplements (low certainty).
1 finding from 1 review
acceptability and safety of treadmill training ‐ Active control group (co‐interventions were similar in both groups) Number of adverse events and drop‐outs · people with Parkinson's disease
1 finding from 1 review
acceptability and safety of treadmill training ‐ No intervention control group (co‐interventions were not similar in both groups) Number of adverse events and drop‐outs · people with Parkinson's disease
1 finding from 1 review
Adverse events (any type) and safety of sealant · patients with myocardial infarction
It is very uncertain whether lidocaine changes safety (AEs; adverse drug reaction): any adverse event compared with pirmenol (very low certainty).
1 finding from 1 review
Safety · Participants with chronic cognitive impairment in traumatic brain injury
1 finding from 1 review
Perinatal mortality (stillbirth ‐ death of fetus prior to birth; neonatal death ‐ death within the first 28 days of birth; or infant death ‐ death after the first 28 days) · pregnant women with a term suspected compromised baby
1 finding from 1 review
Safety (AE, adverse drug reaction): thrombocytopenia Grades 3 or 4 according to National Cancer Institute · Patients with treating MF
Ruxolitinib showed no clear difference in safety (AE, adverse drug reaction): thrombocytopenia Grades 3 or 4… compared with best available therapy (low certainty).
1 finding from 1 review
Safety (AE, adverse drug reaction): thrombocytopenia Grades 3 or 4 according to National Cancer Institute · Patients with treating MF
Ruxolitinib may leads to higher safety (AE, adverse drug reaction): thrombocytopenia Grades 3 or 4… compared with placebo (low certainty).
1 finding from 1 review
Grade 3 to 4 neutropenia · Patients with treating MF
Ruxolitinib may leads to higher safety (AE, adverse drug reaction): neutropenia Grades 3 or 4… compared with placebo (low certainty).
1 finding from 1 review
Safety (AE, adverse drug reaction): anemia Grades 3 or 4 according to National Cancer Institute · Patients with treating MF
Ruxolitinib showed no clear difference in safety (AE, adverse drug reaction): anemia Grades 3 or 4 according… compared with best available therapy (low certainty).
1 finding from 1 review
Intervention not reported
Fetal, neonatal and infant death · Women in preterm labour
It is very uncertain whether the intervention changes fetal, neonatal and infant death (very low certainty).
1 finding from 1 review
Fetal or neonatal mortality · women during pregnancy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fetal or neonatal mortality · women during pregnancy
Universal screening showed no clear difference in fetal and neonatal death compared with case finding (moderate certainty).
1 finding from 1 review
Live birth rate Live fetus delivered beyond 20 completed weeks' gestation · women with anovulatory infertility undergoing ovulation induction with clomiphene citrate
Human chorionic gonadotrophin showed no clear difference in live birth rate Live fetus delivered beyond 20 completed weeks'… compared with no ovulation trigger (low certainty).
1 finding from 1 review
OR 0.97 [0.52, 1.83]
305 participants
Low